Validation of Dozee, a Ballistocardiography-based Device, for Contactless and Continuous Heart Rate and Respiratory Rate Measurement.


Journal

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
ISSN: 2694-0604
Titre abrégé: Annu Int Conf IEEE Eng Med Biol Soc
Pays: United States
ID NLM: 101763872

Informations de publication

Date de publication:
07 2022
Historique:
entrez: 10 9 2022
pubmed: 11 9 2022
medline: 14 9 2022
Statut: ppublish

Résumé

Long-term acquisition of respiratory and heart signals is useful in a variety of applications, including sleep analysis, monitoring of respiratory and heart disorders, and so on. Ballistocardiography (BCG), a non-invasive technique that measures micro-body vibrations caused by cardiac contractions as well as motion caused by breathing, snoring, and body movements, would be ideal for long-term vital parameter acquisition. Turtle Shell Technologies Pvt. Ltd.'s Dozee device, which is based on BCG, is a contactless continuous vital parameters monitoring system. It is designed to measure Heart Rate (HR) and Respiratory Rate (RR) continuously and without contact in a hospital setting or at home. A validation study for HR and RR was conducted using Dozee by comparing it to the vitals obtained from the FDA-approved Patient Monitor. This was done in a sleep laboratory setting over 110 nights in 51 subjects to evaluate HR and over 20 nights in 17 subjects to evaluate RR at the National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India. Approximately 789 hours data for HR and approximately 112 hours data for RR was collected. Dozee was able to achieve a mean absolute error of 1.72 bpm for HR compared to the gold standard ECG. A mean absolute error of ∼1.24 breaths/min was obtained in determining RR compared to currently used methods. Dozee is ideal for long-term contactless monitoring of vital parameters due to its low mean absolute errors in measuring both HR and RR. Clinical Relevance- Continuous and long-term vitals monitoring is known to enable early screening of clinical deterioration, improve patient outcomes and reduce mortality. Current methods of continuous monitoring are overly complex, costly, and rely heavily on patient compliance. The proposed remote vitals monitoring solution based on BCG was found to be at par with gold standard methods of recording HR and RR. As a result, clinicians can use it to effectively monitor patients in both the hospital and at home.

Identifiants

pubmed: 36086663
doi: 10.1109/EMBC48229.2022.9871007
doi:

Substances chimiques

BCG Vaccine 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1939-1943

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH